Article
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity.
Human mutation - 1 Jan 2010
Tchatchou Sandrine, Riedel Angela, Lyer Stefan, Schmutzhard Julia, Strobel-Freidekind Olga, Gronert-Sum Sabine, Mietag Carola, D'Amato Mauro, Schlehe Bettina, Hemminki Kari, Sutter Christian, Ditsch Nina, Blackburn Anneke, Hill Linda Zhai, Jerry D Joseph, Bugert Peter, Weber Bernhard H F, Niederacher Dieter, Arnold Norbert, Varon-Mateeva Raymonda, Wappenschmidt Barbara, Schmutzler Rita K, Engel Christoph, Meindl Alfons, Bartram Claus R, Mollenhauer Jan, Burwinkel Barbara
Abstract excerpt
According to present estimations, the unfavorable combination of alleles with low penetrance but high prevalence in the population might account for the major part of hereditary breast cancer risk. Deleted in Malignant Brain Tumors 1 (DMBT1) has been proposed as a tumor suppressor for breast cancer and other cancer types. Genomewide mapping in mice further identified Dmbt1 as a potential modulator of breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
